Sunday, November 22, 2026

Oman News

Oman secures observer status in International Council for Harmonisation

Oman, represented by the Drug Safety Center at the Ministry of Health, has secured observer status in the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

ONA

info@thearabianstories.com

Sunday, November 22, 2026

MUSCAT: The achievement strengthens Oman’s engagement with international regulatory bodies and provides an opportunity to benefit from global expertise in pharmaceutical quality, safety and efficacy.
The ICH is an international platform that brings together pharmaceutical regulatory authorities and industry representatives to harmonise technical requirements and develop scientific guidelines and standards for medicines.

The observer status will allow Oman to follow international regulatory and scientific developments, exchange expertise, strengthen national capabilities and work towards aligning its pharmaceutical regulatory requirements with internationally recognised guidelines.

During the next phase, the Drug Safety Center plans to train specialists in regulatory assessment, gradually implement ICH guidelines and support the development of local pharmaceutical manufacturing through enhanced technical capabilities at national factories.

The centre also aims to strengthen cooperation and exchange expertise with ICH member countries and participating organisations.

The development forms part of the Ministry of Health’s efforts to advance Oman’s pharmaceutical sector and strengthen its regulatory framework, in line with the objectives of Oman Vision 2040 to build an efficient and sustainable healthcare system.

Close